Patient selection and timing of allogeneic hematopoietic stem cell transplantation for relapsed follicular lymphoma

Abstract

Approximately 20% of patients with FL relapse within 2 years of diagnosis with decreasing sensitivity to treatment. Allo‐HCT is more effective in patients who are in earlier phases of the disease. Autologous hematopoietic cell transplantation should be considered as an option for high‐risk patients who experience failure of chemoimmunotherapy after initial lines of therapy.